News and Announcements
WIN 1 ETH + 6000 BITCAR #selfiewithaBitCar
- Published June 24, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Bitcar are giving away 1 ETH and 6000 BITCAR tokens every 2 weeks
- simply take a photo with a BitCar and use #selfiewithaBitCar when posting to social media
- The competition closes Tuesday the 10th of July, midnight (SGT)
We are giving away 1 ETH and 6000 BITCAR tokens every 2 weeks as a part of our #selfiewithaBitCar campaign!
How to enter
We’d like to see you in your most creative photo with a BitCar! The competition starts today and will be closed by 10th July, midnight (SGT). The lucky winner will be announced on July 11.
- Take a picture of yourself with a supercar or dream car of yours.
- Use the #selfiewithaBitCar hashtag in your post.
- Share publicly on Facebook, Twitter or Instagram.
- One lucky winner will be announced fortnightly, each Wednesday the campaign runs!
Winning Prize
Each lucky winner will receive:
- 6000 BITCAR
- 1 ETH
- BitCar T-shirt, cap and stickers.
What are you waiting for? Be creative and get your #selfiewithaBitCar on!
About BitCar
In a world first, the BitCar platform allows fractionalized ownership and decentralized peer-to-peer trading in Exotic Cars with a new BITCAR token. Imagine being a part-owner of a Ferrari F40, Maserati MC12 or Bugatti Veyron just to name a few. Owners can peg their crypto to these hard assets for protection during times of high crypto volatility.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
